Miss Sani Jiewjinda During 4 - 22 December 2014, 13 persons colluded to manipulate the price of KIAT share to be inconsistent with the normal market condition, causing the price of KIAT share to rise
rise from 7.75 baht to 15.60 baht. The 13 offenders are (1) Mr. Kiatichai Monsereenusorn, (2) Mr. Nam Cholsaipan, (3) Mr. Suppawut Maneerin, (4) Miss Sani Jiewjinda, (5) Mr. Yos Thanarakchoke, (6) Mrs
rise from 7.75 baht to 15.60 baht. The 13 offenders are (1) Mr. Kiatichai Monsereenusorn, (2) Mr. Nam Cholsaipan, (3) Mr. Suppawut Maneerin, (4) Miss Sani Jiewjinda, (5) Mr. Yos Thanarakchoke, (6) Mrs
to rise from Q3/2018 onwards. Q1/2018 Gross Profit The Company and its subsidiaries recorded gross profit of Baht 339 million, a decrease of 28% YoY. This represented gross profit margin of 24.9%, a
-based growth in household purchasing power. At the same time, inflation remains subdued though it is expected to slowly rise. In this regard, the MPC judged that accommodative monetary policy stance would
marketing margin declined from the rise in crude oil price in Q1/2019, which caused the finished oil products cost to increase, while the retail price was slower to adjust. Moreover, with the price fix for
Metropolitan Area (BMA), 18 projects in the provinces, and 1 project overseas), 30 food centers, 7 office towers, 2 hotel properties, 9 high- rise residential projects, 3 of which fully transferred, 4 of which
1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in
hospitals and medical equipment that will support continuous growth momentum in demand for medical devices in Thailand. 4 Due to growth medical device business, the Company plans to develop new products as
, Samutprakarn 5.4 Type of business disposable medical equipment manufacture and distributor. 5.5 Paid-up capital (Before investment) 300 million baht 5.6 Number of ordinary shares The Company holds (Before